You have no items in your shopping cart.
CTLA-4/CD152 Antibody
Description
Images & Validation
−| Tested Applications | ELISA, FA, FACS, In vivo |
|---|---|
| Reactivity | Human, Monkey |
Key Properties
−| Clonality | Monoclonal |
|---|---|
| Target | CTLA-4 / CD152 |
| Source/Expression System | CHO |
| Molecular Weight | 145.38 kDa |
| Purity | >95% |
| Purification | Protein A |
| Endotoxin | <0.001 EU/ug |
| Conjugation | Unconjugated |
Storage & Handling
−| Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
|---|---|
| Buffer/Preservatives | 100 mM Proline/Acetic acid 20mM Arginine pH 5.0 |
| Concentration | Batch dependent |
| Disclaimer | For research use only |
Similar Products
−CTLA-4 / CD152 Reference Antibody [orb1805505]
ELISA, FA, FACS, In vivo
Human
Monoclonal
Unconjugated
1 mg, 100 μgCTLA-4/CD152 Antibody [orb1805824]
ELISA, FA, FACS, In vivo
Human, Monkey
Monoclonal
Unconjugated
100 μg, 1 mgCTLA-4 Antibody [orb2568771]
In vivo
Mouse
Mouse
Monoclonal
Unconjugated
100 mg, 50 mg, 25 mg, 5 mg, 1 mg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Anti-CTLA-4 / CD152 Reference Antibody (ipilimumab) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.

The purity of Anti-CTLA-4 / CD152 Reference Antibody (ipilimumab)is more than 99.37% ;determined by SEC-HPLC.

Human CTLA-4 & Human PD-1 CHO-K cells were stained with Anti-CTLA-4 / CD152 Reference Antibody (ipilimumab) and negative control protein respectively; washed and then followed by PE and analyzed with FACS; EC925=0.2270 μg/mL.

Ipilimumab inhibited the tumor growth of MC38 on huCTLA-4 mice. The result showed significant anti-tumor effects; with an tumor inhibition rate (TGI) of 99.3% at 0.88 mpk at D37.
Quick Database Links
UniProt Details
−Documents Download
Request a Document
Protocol Information
CTLA-4/CD152 Antibody (orb1806363)
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review













